|
![]() Print Staff CV |
|
![]() Print Staff CV |
Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology (October 2024) |
Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) in Chronic Myeloproliferative Neoplasms with Relation to Genetic Burden and Thrombosis (September 2024) |
Management of Primary Immune Thrombocytopenia: Turkish Modified Delphi-Based Consensus Statement for Special Considerations (June 2024) |
Management of Adult Primary Immune Thrombocytopenia: DelphiBased Consensus Recommendations (June 2024) |
Evaluation of Sarcopenia with F-18 FDG PET/CT and relation with disease outcomes in patients with multiple myeloma. (November 2020) |
Sarcopenia in Hodgkin's lymphoma evaluated with 18-FDG PET/CT, focus on age, performance, and treatment. (September 2020) |
The Incidence of Venous Thromboembolism and Impact on Survival in Hodgkin Lymphoma. (August 2020) |
Assessment of Patients with von Willebrand Disease with ISTH/BAT and PBQ Scores (February 2020) |
A case of refractory chronic lymphocytic leukaemia with an unusual course (November 2019) |
Frailty in patients with acute myeloid leukaemia, conceptual misapprehension of chronological age. Umit EG, Baysal M, Demir AM. Eur J Cancer Care (Engl). 2018 Jan 16 (January 2018) |
Real-World Data in Relapsed Refractory Myeloma Patients Treated with Carfilzomib, a Multicenter Turkish Experience (December 2017) |
. CD11c expression in chronic lymphocytic leukemia revisited, related with complications and survival. Umit EG, Baysal M, Durmus Y, Demir AM. Int J Lab Hematol. 2017 Oct;39(5):552-556 (October 2017) |
The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review (September 2024) |
Re: Schelfhout J, Bonafede M, Cappell K, et al. Impact of cytomegalovirus complications on resource utilization and costs following hematopoietic stem cell transplant (April 2020) |
Polypharmacy and potentially inappropriate medication use in older patients with multiple myeloma, related to fall risk and autonomous neuropathy. (January 2020) |
A comment on "a prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia" by Zhou et al (January 2020) |
Genetic Diagnosis of Hereditary Hemorrhagic Telangiectasia: Four Novel Pathogenic Variations in Turkish Patients. (December 2019) |
2126 Economic Analysis of Posaconazole Prophylaxis in Patients with Acute Myeloid Leukemia Undergoing Remission Induction Chemotherapy from a Hospital Management Perspective (December 2017) |
International Society of Hemostasis and Thrombosis Annual Meeting 2024- Bangkok-Thailand Anticoagulation for Venous Thromboembolism (VTE) in patients aged >80 years: a focus on bleeding (July 2024) |
Economic analysis of oral posaconazole prophylaxis in acute myeloid leukemia during remission induction in Turkey. (April 2020) |
European Journal of Cancer Care (November 2020) |